Singh A - Search Results

1

Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.

Bousman CA, Sarris J, Won ES, Chang HS, Singh A, Lee HY, Ham BJ, Tan CH, Lee MS, Ng CH. Bousman CA, et al. Among authors: singh a. J Clin Psychopharmacol. 2014 Oct;34(5):645-8. doi: 10.1097/JCP.0000000000000165. J Clin Psychopharmacol. 2014. PMID: 24943391 Clinical Trial.

2

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Singh AB, et al. Transl Psychiatry. 2012 Nov 27;2(11):e198. doi: 10.1038/tp.2012.115. Transl Psychiatry. 2012. PMID: 23188198 Free PMC article.

3

Psychomotor depressive symptoms may differentially respond to venlafaxine.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Singh AB, et al. Int Clin Psychopharmacol. 2013 May;28(3):121-6. doi: 10.1097/YIC.0b013e32835f1b9f. Int Clin Psychopharmacol. 2013. PMID: 23442739 Free article.

4

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.

Ng C, Sarris J, Singh A, Bousman C, Byron K, Peh LH, Smith DJ, Tan CH, Schweitzer I. Ng C, et al. Among authors: singh a. Hum Psychopharmacol. 2013 Sep;28(5):516-22. doi: 10.1002/hup.2340. Hum Psychopharmacol. 2013. PMID: 24014145

5

Antidepressant pharmacogenetics.

Singh AB, Bousman CA, Ng C, Berk M. Singh AB, et al. Curr Opin Psychiatry. 2014 Jan;27(1):43-51. doi: 10.1097/YCO.0000000000000023. Curr Opin Psychiatry. 2014. PMID: 24270480 Review.

6

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation.

Singh AB, Bousman CA, Ng CH, Berk M. Singh AB, et al. Aust N Z J Psychiatry. 2013 Dec;47(12):1191-5. doi: 10.1177/0004867413510212. Aust N Z J Psychiatry. 2013. PMID: 24280998

7

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study.

Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Singh AB, et al. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):53-61. doi: 10.9758/cpn.2015.13.1.53. Clin Psychopharmacol Neurosci. 2015. PMID: 25912538 Free PMC article.

8

Mental health system development in Asia: Does Australia have a role?

Arandjelovic K, Eyre HA, Forbes MP, Bauer R, Aggarwal S, Singh AB, Baune BT, Everall I, Berk M, Ng C. Arandjelovic K, et al. Among authors: singh ab. Aust N Z J Psychiatry. 2016 Sep;50(9):834-41. doi: 10.1177/0004867416647798. Epub 2016 May 10. Aust N Z J Psychiatry. 2016. PMID: 27164923 Free article. Review.

9

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study.

Bousman CA, Müller DJ, Ng CH, Byron K, Berk M, Singh AB. Bousman CA, et al. Among authors: singh ab. Pharmacogenet Genomics. 2017 Jan;27(1):1-6. doi: 10.1097/FPC.0000000000000253. Pharmacogenet Genomics. 2017. PMID: 27779571 Free PMC article.

10

Antidepressant Pharmacogenetics.

Singh AB, Bousman CA. Singh AB, et al. Am J Psychiatry. 2017 May 1;174(5):417-418. doi: 10.1176/appi.ajp.2017.17020173. Am J Psychiatry. 2017. PMID: 28457163 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,376 results

Search Page